Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
AstraZeneca Says Lynparza/Imfinzi Combo Shows Strong Clinical Benefit Vs. Chemotherapy In Endometrial Cancer
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Health Care Recent News
Eco-Friendly CBD Honey Hits Shelves: LEEF Brands' Sustainable Sweets For Health Enthusiasts
How to Battle Burnout While Protecting Your Most Valuable Asset — Your People
Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data
Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival
What's Going On With Abbott Laboratories Stock On Friday?
Bristol Myers' Breyanzi Scores Second FDA Approval For Blood Cancers Therapy
FDA Approves BeiGene's First Drug Candidate Produced Through Its Immuno-Oncology Program For Esophageal Cancer
Gilead's Aggressive Push Beyond HIV Treatments - Plans To Increase Cancer-Focused CAR-T Treatment Production
FDA Approves Intuitive Surgical's Da Vinci 5 Surgical System, Analyst Outlines Sees Long-Term Growth Potential
FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring
What's Going On With Cancer Focused-Geron Stock On Friday?
Grifols Gets Downgraded: Fitch, S&P Flag Cash Flow Concerns At Pharma Company
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall